Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triticum Aestivum in Obesity
NCT06501248Phase 3Unknown
- Sponsor
- Coordinación de Investigación en Salud
- Start
- Jul 2022
- Primary completion
- Aug 2024
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial (2 arms), sponsored by Coordinación de Investigación en Salud. Primary endpoints: Fasting Plasma Glucose at 120 days, Insulin Sensitivity at 120 days and 9 more. Status: unknown.
Beyond the preview
Go deeper on NCT06501248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06501248.